Atlas Trials

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Clinical trial NCT04802980 · UNKNOWN

Trial details

NCT number
NCT04802980
Sponsor
Huabo Biopharm Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2020-04-28
Primary completion
2023-07-15
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.